Bio-Techne (TECH) FCF Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -2,228.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9,545.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -7.75 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -3,088.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4,612.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 14,060.00
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn 1,172.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,172.00
Dec 31, 2025 439.00
Sep 30, 2025 -231,850.00
Jun 30, 2025 -149.00
Mar 31, 2025 -1,018.00
Dec 31, 2024 -763.00
Sep 30, 2024 247.00
Jun 30, 2024 -2,395.00
Mar 31, 2024 -511.00
Dec 31, 2023 -967.00
Sep 30, 2023 -1,043.00
Jun 30, 2023 849.00
Mar 31, 2023 -746.00
Dec 31, 2022 -874.00
Sep 30, 2022 230,987.00
Jun 30, 2022 784.00
Mar 31, 2022 119.00
Dec 31, 2021 969.00
Sep 30, 2021 -520.00
Jun 30, 2021 999.00